Sign In
Buy ARWR
$82.00
+0.180 (+0.220%)
At Close: Jun 22, 2026
Arrowhead Pharmaceuticals Announces Precautionary Measures to Mitigate Effects of Novel Coronavirus (COVID-19) Spread
08:10pm, Tuesday, 17'th Mar 2020
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead provides update related to COVID-19 efforts
Are Investors Undervaluing Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) By 21%?
07:17pm, Tuesday, 17'th Mar 2020
In this article we are going to estimate the intrinsic value of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) by...
Renaissance Technologies LLC Has $45.82 Million Stock Holdings in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)
12:04pm, Tuesday, 17'th Mar 2020
Renaissance Technologies LLC increased its position in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) by 9.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securitie
BMO likes Blueprint Medicines in premarket analyst action
11:31am, Tuesday, 17'th Mar 2020
Arrowhead Pharmaceuticals (NASDAQ:ARWR) initiated with Neutral rating and $45 (107% upside) price target at Goldman Sachs.Ocular Therapeutics (NASDAQ:OCUL) initiated with Buy rating and $8 (97% upside
